SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

Debut, the biotech beauty leader, announced today the launch of BeautyORB™, an AI-powered innovation engine that provides a ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with ...